Skip to main content
. 2026 Feb 6;17:1747121. doi: 10.3389/fphar.2026.1747121

TABLE 4.

Comparison of incidence of MACE among patients with different treatment regimens in matched cohort (%).

Metabolic type Therapeutic schedule Number Number of MACE (n) Incidence of MACE (%) χ 2 P
EM type Clop. 104 7 6.73 - -
Tica. 104 6 5.77 0.01 0.928
IM type Clop. 113 25 22.12 - -
Tica. 113 13 11.50 4.55 0.033
PM type Clop. 40 12 30.00 - -
Tica. 40 4 10.00 5.00 0.025

Data in this table are based on propensity score-matched cohorts. MACE: major adverse cardiovascular event.